Log in

Broncho-Vaxom® inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187

  • Histamine Release from Murine Serosal Mast Cells and Human Basophils
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Broncho-Vaxom (BV) inhibited in dose-dependent manner the release of histamine from and degranulation of isolated rat peritoneal mast cells stimulated with compound 48/80 and the ionophore A23187. Inhibition persisted after removal of BV from the incubation medium before stimulation, but did not occur when bovine serum albumin (BSA) was used instead of BV. Binding of BV to mast cells was observed by electron microscopy on cells that had been incubated with colloidal-gold labelled BV. There was no significant difference between the binding of BV gold and BSA gold to the mast cells. Washing before fixation removed most of the BV gold from the cells. This study establishes BV as anin vitro histamine release inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. Clot and M. Andary,Immunostimulation induite par un lysat bactérien lyophilisé. Etude in vitro des réponses spécifiques et non spécifiques. Méd et Hyg., Genève38, 2776–2782 (1980).

    Google Scholar 

  2. A. Bosch, F. Lucena, R. Parés and J. Jofre,Bacterial immunostimulant (Broncho-Vaxom) versus levamisole on the humoral immune response in mice. J. Immunopharmacol.5, 107–116 (1983).

    PubMed  Google Scholar 

  3. A. Németh and P. Röhlich,Rapid separation of rat peritoneal mast cells with Percoll. Eur. J. Cell Biol.20, 272–275 (1980).

    PubMed  Google Scholar 

  4. R. Martin du Pan and B. Köchli,Interferon induction by the bacterial lysate Broncho-Vaxom ®:a double-blind clinical study in children.Kinderarzt 15, 646–651 (1984).

    Google Scholar 

  5. J. M. Puigdollers, G. Rodés Serna, I. Hernandez del Rey, M. T. Tillo Barruffet and J. Jofre Torroella,Immunoglobulin production in man stimulated by an orally administered bacterial lysate. Respiration40, 142–149 (1980).

    PubMed  Google Scholar 

  6. A. G. Palma-Carlos and M. L. Palma-Carlos,Oral immunotherapy with a bacterial lysate in asthma and recurrent respiratory infections. Méd. et Hyg., Genève43, 2718–2720 (1985).

    Google Scholar 

  7. T. S. C. Orr, D. E. Hall, J. M. Gwilliam and J. S. G. Cox,The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by Compound 48/80. Life Sci.10, 805–812 (1971).

    Google Scholar 

  8. U. Martin and D. Römer,The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene. Arzneimittelforschung28 (I), 770–782 (1978).

    PubMed  Google Scholar 

  9. P. A. Shore, A. Burkhalter and V. H. Cohn,A method for the fluorometric assay of histamine in tissues. J. Pharmacol.127, 182–186 (1959).

    Google Scholar 

  10. J. W. Slot and H. J. Geuze,A new method of preparing gold probes for multiple labelling cytochemistry. Eur. J. Cell Biol.38, 87–93 (1985).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Németh, A., Magyar, P. Broncho-Vaxom® inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187. Agents and Actions 27, 43–45 (1989). https://doi.org/10.1007/BF02222193

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02222193

Keywords

Navigation